U.S. Office REITs Stock News

NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Three Growth Tech Stocks Where AI Moats Meet Premium Valuations

With the Federal Reserve widely expected to keep interest rates steady in June and July, markets are getting a rare dose of predictability. That kind of policy pause can give investors more room to focus on company fundamentals rather than guessing the next rate move. This article looks at three large North American technology related stocks exposed to this news, all screened for solid performance and financial health metrics. You will see how a stable rate outlook may shape the opportunity...
NYSE:GME
NYSE:GMESpecialty Retail

What GameStop (GME)'s $2 Billion Buyback And eBay Bid Mean For Shareholders

In early June 2026, GameStop reported first-quarter sales of US$835.3 million and net income of US$389.6 million, while unveiling a new US$2.00 billion share repurchase program running through 2029. At the same time, CEO Ryan Cohen launched a hostile takeover bid for eBay, signaling an effort to recast GameStop as a broader e-commerce and collectibles platform rather than a traditional bricks-and-mortar gaming retailer. We’ll now examine how GameStop’s aggressive US$2.00 billion buyback plan...
NYSE:BFH
NYSE:BFHConsumer Finance

Do Bread Financial’s Improving Credit Metrics Quietly Redefine Its Earnings Resilience Story (BFH)?

Bread Financial Holdings recently presented at the Morgan Stanley US Financials Conference in New York, where Executive VP & CFO Perry S. Beberman highlighted the company’s improving credit trends, including lower net principal losses and easing delinquencies. Analysts are increasingly focusing on how these better credit metrics, together with a run of positive earnings surprises and capital return activity, may be reshaping assessments of Bread Financial’s earnings power and risk...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Travere Therapeutics (TVTX) Is Up 10.5% After FILSPARI Shows Durable FSGS Benefit And Drives Non-GAAP Profitability – Has The Bull Case Changed?

Earlier in June 2026, Travere Therapeutics reported long-term Phase 3 DUPLEX open-label extension data showing durable proteinuria reductions and up to five years of tolerability for FILSPARI in focal segmental glomerulosclerosis, alongside its first non-GAAP profitable quarter driven by the drug’s commercial performance. This combination of sustained clinical benefit in a rare kidney disease and an early move into profitability highlights how central FILSPARI has become to Travere’s...
NasdaqGS:INTR
NasdaqGS:INTRBanks

If Cheaper Oil Reshapes Global Travel These 3 Banks Stand Out

The sudden progress toward a US Iran peace deal and the potential reopening of the Strait of Hormuz has pulled oil prices lower and shifted attention to companies that are sensitive to fuel costs and global stability. For investors, this is a moment to reassess which stocks might benefit if cheaper energy and reduced geopolitical risk persist, and which could lose some pricing power. This article highlights 3 stocks from a Global Airlines and Travel screener that appear positively exposed to...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Is PagSeguro (PAGS) Still Overlooked Despite Its Growing PagBank Platform And Analyst Reappraisal?

In recent days, PagSeguro Digital has drawn increased attention as analysts highlighted its five-year track record of rising revenue and operating profit, along with the expansion of its PagBank digital banking platform despite Brazil’s challenging macroeconomic backdrop. What stands out is that some analysts now view PagSeguro as undervalued relative to its earnings power, arguing that the market may be underappreciating both its diversified fintech model and its resilience in a volatile...
NYSE:GEL
NYSE:GELOil and Gas

Should Genesis Energy’s Strengthened Balance Sheet and Offshore Projects Shift the Risk Profile for GEL Investors?

Earlier this month, Genesis Energy, L.P. presented at Bank of America’s Energy & Power Credit Conference and RBC Capital Markets’ Global Energy, Power & Infrastructure Conference in New York, highlighting its Gulf of Mexico offshore pipeline network and recent balance sheet improvements. The company’s combination of reduced debt maturities, lower interest burden, and ramping Shenandoah and Salamanca projects underscores a business increasingly anchored by long-term, tariff-based cash...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

How Investors May Respond To Personalis (PSNL) CE Mark Win For Its MRD Blood Collection Kits

Earlier this month, Personalis announced clinical data from the 2026 ASCO meeting showing its NeXT Personal assay can detect minimal residual disease at ultra-low levels across six solid tumor types, with strong correlations to relapse and progression risk in colorectal, lung, ovarian, endometrial, melanoma, and renal cancers. Shortly afterward, the company received CE Mark Class A approval for its EDTA and cfDNA Blood Collection Kits, opening the door for broader use of its MRD ecosystem in...
NYSE:AMR
NYSE:AMRMetals and Mining

Does Sector Upswing And Insider Buying Shift The Risk‑Reward Balance For Alpha Metallurgical (AMR)?

In recent days, Alpha Metallurgical Resources benefited from a sector-wide upswing in coking coal producers, as improving sentiment toward metallurgical coal lifted the company alongside peers such as Warrior Met Coal and Ramaco Resources. At the same time, insider purchases totaling about US$4.40 million and indications that the shares may be trading above intrinsic value add an interesting contrast between internal confidence and external valuation assessments. We’ll now examine how this...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Pharmaceuticals (CRVS) Is Up 7.3% After Promising Soquelitinib Data And Extended Cash Runway

In recent months, Corvus Pharmaceuticals reported encouraging Phase 1 results for its oral ITK inhibitor soquelitinib in atopic dermatitis, showing early efficacy signals alongside a clean safety profile and extending its cash runway into the second quarter of 2028. These developments, coupled with upbeat coverage from investment commentators highlighting soquelitinib’s potential to compete in immunology and attract larger partners, have drawn fresh attention to Corvus’s pipeline and funding...
NYSE:ASAN
NYSE:ASANSoftware

Is Asana’s (ASAN) New Human‑Agent OS Quietly Recasting Its Core Competitive Moat?

In early June 2026, Asana, Inc. launched an “operating system for human-agent teams,” centered on its Agentic Work Management suite, AI Teammates, Asana Dash, and new industry-specific agents that coordinate humans and AI across tools like Slack, Gmail, and major enterprise systems. By tightly integrating its AI agents with StackAI to orchestrate complex workflows across CRMs, ERPs, and collaboration platforms, Asana is positioning its platform as a central hub for AI-powered work execution...
NYSE:OMC
NYSE:OMCMedia

McCann Study On Upward Class Puts Omnicom Valuation In Focus

McCann, an Omnicom Group (NYSE:OMC) subsidiary, released a new global study on brand relevance and growth strategies. The research introduces the "Upward Class," a large and influential consumer group shaping how brands grow worldwide. The findings highlight changing expectations for how brands connect with this audience and maintain relevance. For Omnicom Group, a global advertising and marketing services company, this kind of research sits close to the core of its business. As clients...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Skyward Specialty (SKWD) Is Up 8.5% After Expanding Into Autonomous Risks And Lloyd’s Syndicate Launch

Recently, Skyward Specialty Insurance Group reported that its diversified specialty lines, accident and health momentum, disciplined underwriting, and expense controls have combined with Apollo acquisition synergies to support stronger recurring premium and fee-based income streams. An interesting angle is Skyward’s push into emerging areas like autonomous vehicle insurance and the launch of Lloyd’s Syndicate 1972, which together broaden its reinsurance capacity and expand its reach into...
NYSE:OPLN
NYSE:OPLNCommercial Services

Openlane (OPLN) Stock After New Board Appointments How Does The Valuation Stack Up

OPENLANE (OPLN) has drawn investor attention after adding two seasoned leaders to its Board of Directors, a governance shift that puts board composition, oversight and execution in focus for the wholesale digital auto marketplace. See our latest analysis for OPENLANE. While the latest share price of $37.83 is down 2.25% over the last day, OPENLANE’s 30 day share price return of 8.40% and 90 day share price return of 37.86% sit alongside a 1 year total shareholder return of 65.56%. This points...
NasdaqGM:HPK
NasdaqGM:HPKOil and Gas

Do Rising Middle East Supply Risks Redefine HighPeak Energy’s Role as a Swing Producer (HPK)?

Earlier this week, U.S. self-defense strikes on Iran heightened Middle East tensions, increasing concerns about potential disruptions to Iranian oil supply and shifting attention to alternative producers. This backdrop has put U.S. shale operators such as HighPeak Energy in sharper focus as potential contributors to any future global supply gaps, without necessarily altering the company’s longer-term fundamentals. Next, we’ll examine how heightened Middle East supply risk, and HighPeak’s...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Perrigo (PRGO) Stock Valuation After CEO Resignation And Reaffirmed 2026 Earnings Guidance

What the leadership shake up and guidance update mean for Perrigo stock Perrigo (PRGO) just combined a sudden leadership change with a reaffirmed 2026 earnings outlook, after CEO and President Patrick Lockwood-Taylor resigned over personal conduct issues unrelated to the company’s business or financials. The Board has moved quickly by naming existing director Albert A. Manzone as Interim CEO and President and launching a search for a permanent successor. This signals an effort to keep the...
NYSE:IFF
NYSE:IFFChemicals

International Flavors & Fragrances (IFF) Is Up 7.2% After Benchmark Highlights Planned Food Ingredients Divestiture

Earlier this week, Benchmark began covering International Flavors & Fragrances, highlighting the company’s plan to divest its Food Ingredients segment as a key step in reshaping the business mix. At the same time, substantial recent insider purchases and mixed assessments of financial strength have drawn attention to the balance of opportunity and risk in IFF’s repositioning efforts. We’ll now examine how Benchmark’s coverage initiation, centered on the planned Food Ingredients divestiture,...
NYSE:AMPX
NYSE:AMPXElectrical

Amprius Technologies (AMPX) Stock Valuation After Drone Battery Deal And Short Seller Scrutiny

Why Amprius Technologies Stock Is Back in Focus Amprius Technologies (AMPX) is drawing attention after announcing a collaboration to supply silicon anode lithium-ion batteries for Matternet’s M2 delivery drones, while also facing short seller allegations about its reported orders and disclosures. See our latest analysis for Amprius Technologies. Recent volatility has been sharp, with the share price falling 4.62% in the last session, 17.17% over the week and 12.73% over 90 days. At the same...
NYSE:WM
NYSE:WMCommercial Services

Waste Management (WM) Stock Valuation After Stericycle Deal And New COO Appointment

Event: Stericycle Deal and New COO Put Healthcare and Sustainability in Focus Waste Management (WM) has moved deeper into healthcare waste and sustainability by acquiring Stericycle and naming Tara Hemmer as chief operating officer. This combination sharpens attention on the stock’s evolving business mix and margin profile. See our latest analysis for Waste Management. WM’s recent news sits against a mixed share performance, with the stock falling 7.39% on a 90 day share price return and a 1...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

How Investors Are Reacting To HealthEquity (HQY) AI Automation Push Amid Cybersecurity Scrutiny

Earlier this month, HealthEquity reported strong fiscal 2027 first-quarter results, highlighting growth in Health Savings Accounts and assets under management, supported by high client retention and enterprise wins. The company also emphasized expanding AI-driven automation while continuing to address ongoing litigation and regulatory scrutiny tied to a prior cybersecurity incident, underscoring how operational efficiency and data protection are becoming central to its business model. We’ll...
NYSE:ONTO
NYSE:ONTOSemiconductor

If Global Tensions Reshape Energy Flows These Stocks Could Shine

Energy stocks are again in the spotlight as investors watch headlines about a possible U.S. Iran deal, G7 talks on wars and trade, and fresh debates on AI and global security. These stories are not just politics; they can influence oil supply routes, risk premiums, and sentiment toward large producers and refiners. For investors, that mix can create pockets of opportunity and pockets of risk. This article highlights 3 large energy stocks from our screener that look particularly exposed to...
NasdaqGS:SCSC
NasdaqGS:SCSCElectronic

ScanSource (SCSC) Stock Valuation Update After Recent Share Price Momentum

Recent performance snapshot With no single headline event driving trading, ScanSource (SCSC) has quietly drawn attention after its stock price closed at US$50.01, with returns of 0.9% over the past day and 7.1% over the past week. Over the past month and the past 3 months, the stock shows returns of 18.8% and 41.1%. Year to date and 1-year total returns stand at 28.0% and 23.7%, respectively, putting recent moves into clearer context for investors. See our latest analysis for...
NYSE:CCI
NYSE:CCISpecialized REITs

How Investors Are Reacting To Crown Castle (CCI) Fiber Exit And Debt-Focused Balance Sheet Reset

In May 2026, Crown Castle completed the sale of its fiber and small-cell businesses, generating about US$8.40 billion in proceeds, committing over US$7.00 billion to debt reduction, and authorizing a US$1.00 billion share repurchase program as it reset its balance sheet. This move leaves Crown Castle as a focused U.S. tower infrastructure company, with a simpler business model and management guiding to improved 2026 cash flow metrics and ongoing capital returns. Next, we’ll assess how Crown...